Mori A - Search Results

1

Antidepressant activity of the adenosine A2A receptor antagonist, istradefylline (KW-6002) on learned helplessness in rats.

Yamada K, Kobayashi M, Shiozaki S, Ohta T, Mori A, Jenner P, Kanda T. Yamada K, et al. Among authors: mori a. Psychopharmacology (Berl). 2014 Jul;231(14):2839-49. doi: 10.1007/s00213-014-3454-0. Epub 2014 Feb 2. Psychopharmacology (Berl). 2014. PMID: 24488405

2

Distribution of adenosine A(2A) receptor antagonist KW-6002 and its effect on gene expression in the rat brain.

Aoyama S, Koga K, Mori A, Miyaji H, Sekine S, Kase H, Uchimura T, Kobayashi H, Kuwana Y. Aoyama S, et al. Among authors: mori a. Brain Res. 2002 Oct 25;953(1-2):119-25. doi: 10.1016/s0006-8993(02)03277-8. Brain Res. 2002. PMID: 12384245

3

Modulation of GABAergic transmission in the striatopallidal system by adenosine A2A receptors: a potential mechanism for the antiparkinsonian effects of A2A antagonists.

Mori A, Shindou T. Mori A, et al. Neurology. 2003 Dec 9;61(11 Suppl 6):S44-8. doi: 10.1212/01.wnl.0000095211.71092.a0. Neurology. 2003. PMID: 14663009

4

[Recent and potential drug candidates for treatment of Parkinson's disease].

Kanda T, Mori A. Kanda T, et al. Among authors: mori a. Nihon Yakurigaku Zasshi. 2008 Apr;131(4):275-80. doi: 10.1254/fpj.131.275. Nihon Yakurigaku Zasshi. 2008. PMID: 18408338 Review. Japanese. No abstract available.

5

Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex.

Kadowaki Horita T, Kobayashi M, Mori A, Jenner P, Kanda T. Kadowaki Horita T, et al. Among authors: mori a. Psychopharmacology (Berl). 2013 Dec;230(3):345-52. doi: 10.1007/s00213-013-3158-x. Epub 2013 Jun 10. Psychopharmacology (Berl). 2013. PMID: 23748382

6

Antidepressant-like activity of the adenosine A(2A) receptor antagonist, istradefylline (KW-6002), in the forced swim test and the tail suspension test in rodents.

Yamada K, Kobayashi M, Mori A, Jenner P, Kanda T. Yamada K, et al. Among authors: mori a. Pharmacol Biochem Behav. 2013 Dec;114-115:23-30. doi: 10.1016/j.pbb.2013.10.022. Epub 2013 Nov 4. Pharmacol Biochem Behav. 2013. PMID: 24201052

7

Adenosine A₂A-receptor antagonist istradefylline enhances the motor response of L-DOPA without worsening dyskinesia in MPTP-treated common marmosets.

Uchida S, Tashiro T, Kawai-Uchida M, Mori A, Jenner P, Kanda T. Uchida S, et al. Among authors: mori a. J Pharmacol Sci. 2014;124(4):480-5. doi: 10.1254/jphs.13250fp. Epub 2014 Mar 28. J Pharmacol Sci. 2014. PMID: 24681641 Free article.

8

Mode of action of adenosine A2A receptor antagonists as symptomatic treatment for Parkinson's disease.

Mori A. Mori A. Int Rev Neurobiol. 2014;119:87-116. doi: 10.1016/B978-0-12-801022-8.00004-0. Int Rev Neurobiol. 2014. PMID: 25175962 Review.

9

The adenosine A2A receptor antagonist, istradefylline enhances the anti-parkinsonian activity of low doses of dopamine agonists in MPTP-treated common marmosets.

Uchida S, Soshiroda K, Okita E, Kawai-Uchida M, Mori A, Jenner P, Kanda T. Uchida S, et al. Among authors: mori a. Eur J Pharmacol. 2015 Jan 15;747:160-5. doi: 10.1016/j.ejphar.2014.11.038. Epub 2014 Dec 11. Eur J Pharmacol. 2015. PMID: 25499739

10

The adenosine A2A receptor antagonist, istradefylline enhances anti-parkinsonian activity induced by combined treatment with low doses of L-DOPA and dopamine agonists in MPTP-treated common marmosets.

Uchida S, Soshiroda K, Okita E, Kawai-Uchida M, Mori A, Jenner P, Kanda T. Uchida S, et al. Among authors: mori a. Eur J Pharmacol. 2015 Nov 5;766:25-30. doi: 10.1016/j.ejphar.2015.09.028. Epub 2015 Sep 28. Eur J Pharmacol. 2015. PMID: 26415982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,606 results

Search Page

Filters